DOI QR코드

DOI QR Code

신증후군 환아에서 발생한 독성표피괴사용해 치료를 위해 사용된 고용량 스테로이드로 인한 정신질환 1례

A case of steroid-induced psychosis in a child having nephrotic syndrome with toxic epidermal necrolysis

  • 김세윤 (영남대학교 의과대학 소아과학교실) ;
  • 이재민 (영남대학교 의과대학 소아과학교실) ;
  • 박용훈 (영남대학교 의과대학 소아과학교실)
  • Kim, Sae Yoon (Department of Pediatrics, Yeungnam University College of Medicine) ;
  • Lee, Jae Min (Department of Pediatrics, Yeungnam University College of Medicine) ;
  • Park, Yong Hoon (Department of Pediatrics, Yeungnam University College of Medicine)
  • 투고 : 2009.09.15
  • 심사 : 2009.12.10
  • 발행 : 2010.03.15

초록

독성표피괴사용해(TEN)와 스티븐-존슨 증후군(SJS)은 약물이나 감염에 의해 발생하는 피부점막을 침범하는 드물지만 치명적인 질병이다. 스테로이드는 TEN의 치료에 많이 이용되어왔지만, 아직까지도 논쟁중이다. 스테로이드에 의한 정신과적 영향은 두통, 불면증, 우울증, 심리질환 등이 있다. 스테로이드에 의한 정신질환에서 치료는 스테로이드의 감량 또는 중단이고, 항정신성 약물을 투여한다. 신증후군으로 진단된 11세 남아에서 스테로이드 치료 후 관해상태에서 유지치료를 시행하고 있던 중에 TEN이 발생하였다. 저자들은 이 환아에서 치료목적으로 투여한 고용량 스테로이드 정맥주사로 인해 정신질환이 동반되었고, 이후 스테로이드 감량과 항정신성 약물과 면역글로불린으로 증상이 호전되는 것을 경험하여 이를 보고하는 바이다.

Toxic epidermal necrolysis (TEN) and Stevens Johnson syndrome (SJS) are rare, life-threatening mucocutaneous -diseases, usually attributable to drugs and infections. Corticosteroids have been used in the management of TEN for the last 30 years. This remains controversial and is still much debated. TEN can occur despite administration of high doses of systemic corticosteroids. The psychiatric side effects of corticosteroids can include headache, insomnia, depression, and mood disorders with or without psychotic episodes. Steroid-induced psychosis is dealt with by tapering or discontinuing the steroid; antipsychotics are also sometimes used. We report a case of an 11-year-old boy who was admitted with TEN. He had also been diagnosed as having nephrotic syndrome in the past. Remission was achieved through induction therapy and by maintaining the use of steroids. After a full-dose intravenous dexamethasone for TEN, he showed psychotic symptoms. We diagnosed him as having steroid-induced psychosis. We tapered the steroid use and initiated an atypical antipsychotic medication, olazapine and intravenous immunoglobulin (IV-IG). His symptoms dramatically improved and he was discharged.

키워드

참고문헌

  1. Mukasa Y, Craven N. Management of toxic epidermal necrolysis and related syndromes. Postgrad Med J 2008;84:60-5 https://doi.org/10.1136/pgmj.2007.061465
  2. Chave TA, Mortimer NJ, Sladden MJ, Hall AP, Hutchinson PE. Toxic epidermal necrolysis: current evidence, practical management and future directions. Br J Dermatol 2005;153:241-53 https://doi.org/10.1111/j.1365-2133.2005.06721.x
  3. Lauerma AI, Reitamo S, Maibach HI. Systemic hydrocortisone/cortisol induces allergic skin reactions in presensitized subjects. J Am Acad Dermatol 1991;24:182-5 https://doi.org/10.1016/0190-9622(91)70024-V
  4. Benyamin R, Vallejo R, Kramer J, Rafeyan R. Corticosteroid induced psychosis in the pain management setting. Pain Physician 2008;11:917-20
  5. Herg$\"{u}$ner S, Bilge I, Yavuz YA, Tüzün DU. Steroid-induced psychosis in an adolescent: treatment and prophylaxis with risperidone. Turk J Pediatr 2006;48:244-7
  6. Revuz J, Roujeau JC, Guillaume JC, Penso D, Touraine R. Treatment of toxic epidermal necrolysis. Arch Dermatol 1987;123:1156-8 https://doi.org/10.1001/archderm.123.9.1156
  7. Kim DW, Jung DE, Koo JW. Steroid and enalapril therapypossible cause of toxic epidermal necrolysis. Korean J Pediatr 2006;49:332-6 https://doi.org/10.3345/kjp.2006.49.3.332
  8. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7 https://doi.org/10.1056/NEJM199512143332404
  9. Werhli P, Viard I, Bullani R, Tschopp J, French LE. Death receptors in cutaneous in cutaneous biology and disease. J Invest Dermatol 2000;115:141-8 https://doi.org/10.1046/j.1523-1747.2000.00037.x
  10. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-85 https://doi.org/10.1056/NEJM199411103311906
  11. Trent JT, Kirsner RS, Romanelli P, Kerdel FA. Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience. Arch Dermatol 2003;139:39-43 https://doi.org/10.1001/archderm.139.1.39
  12. Prins C, Kerdel FA, Padilla RS, Hunziker T, Chimenti S, Viard I, et al. Treatment of toxic epidermal necrolysis with highdose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 2003;139:26-32 https://doi.org/10.1001/archderm.139.1.26
  13. Kamanabroo D, Schmitz-Landgraf W, Czarnetzki BM. Plasmapheresis in severe drug-induced toxic epidermal necrolysis. Arch Dermatol 1985;121:1548-9 https://doi.org/10.1001/archderm.121.12.1548
  14. Wada K, Yamada N, Sato T, Suzuki H, Miki M, Lee Y, et al. Corticosteroid -induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures. Psychosomatics 2001;42:461-6 https://doi.org/10.1176/appi.psy.42.6.461
  15. Schieveld JN, Lousberg R, Berghmans E, Smeets I, Leroy PL, Vos GD, et al. Pediatric illness severity measures predict delirium in a pediatric intensive care unit. Crit Care Med 2008;36:1933-6 https://doi.org/10.1097/CCM.0b013e31817cee5d
  16. Schieveld JN, Leroy PL, van Os J, Nicolai J, Vos GD, Leentjens AF. Pediatric delirium in critical illness: phenomenology, clinical correlates and treatment response in 40 cases in the pediatric intensive care unit. Intensive Care Med 2007;33:1033-40 https://doi.org/10.1007/s00134-007-0637-8
  17. Clark LD, Bauer W, Cobb S. Preliminary observations on mental disturbances occurring in patients under therapy with cortisone and ACTH. N Engl J Med 1952;246:205-16 https://doi.org/10.1056/NEJM195202072460601
  18. Purdon SE, Jones BD, Stip E, Labelle A, Addington D, David SR, et al. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Arch Gen Psychiatry 2000;57:249-58 https://doi.org/10.1001/archpsyc.57.3.249
  19. Soliday E, Grey S, Lande MB. Behavioral effects of corticosteroids in steroid-sensitive nephrotic syndrome. Pediatrics. 1999;104:e51 https://doi.org/10.1542/peds.104.4.e51
  20. Lopez-Medrano F, Cervera R, Trejo O, Font J, Ingelmo M. Steroid induced psychosis in systemic lupus erythematosus: a possible role of serum albumin level. Ann Rheum Dis 2002;61:562-3 https://doi.org/10.1136/ard.61.6.562

피인용 문헌

  1. Toxic epidermal necrolysis associated with deflazacort therapy with nephrotic syndrome vol.33, pp.4, 2010, https://doi.org/10.1016/j.krcp.2014.08.002
  2. Two Cases of Toxic Epidermal Necrolysis Associated with Deflazacort Therapy in Nephrotic Syndrome: Successfully Treated with Cyclosporine A vol.20, pp.2, 2010, https://doi.org/10.3339/jkspn.2016.20.2.97